VS
stockvs
Go to ScreenerHub
AZN.L

AZN.L vs NVO

NVO

In the past 12 months, AZN.L returned +21% while NVO lost 52%.

AZN.L
AZN.L

AstraZeneca PLC

$14,364.00
-5.3%(1M)
Market Cap222.8B
Healthcare
Drug Manufacturers - General
GB
P/E Ratio29.12
ROE23.0%
P/B Ratio6.21
Dividend Yield1.6%
NVO
NVO

Novo Nordisk A/S

$38.58
-21.9%(1M)
Market Cap171.5B
Healthcare
Drug Manufacturers - General
DK
P/E Ratio10.78
ROE61.1%
P/B Ratio5.69
Dividend Yield4.7%
Performance Comparison

Historical returns across multiple timeframes

AZN.L leads 8/8
AZN.L

AZN.L

AstraZeneca PLC

+20.7%

1Y Return

NVO

NVO

Novo Nordisk A/S

-51.9%

1Y Return

AZN.L
AZN.L
NVO
NVO

Short Term

1M-6M

AZN.L
+9.2%

Medium Term

YTD-1Y

AZN.L
+13.2%

Long Term

3Y-10Y

AZN.L
+130.1%

Valuation

Compare price multiples and valuation ratios

AZN.L: 0NVO: 5
MetricAZN.LNVOWinner
P/E Ratio

Price to earnings ratio

29.1210.78NVO
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

5.083.57NVO
P/B Ratio

Price to book ratio

6.215.69NVO
P/FCF Ratio

Price to free cash flow ratio

29.4619.66NVO
EV/EBITDA

Enterprise value to EBITDA

16.167.56NVO
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

AZN.L: 0NVO: 6
MetricAZN.LNVOWinner
Gross Margin

Gross profit margin

78.2%81.0%NVO
Operating Margin

Operating profit margin

23.3%41.3%NVO
Net Margin

Net profit margin

17.4%33.1%NVO
ROE

Return on equity

23.0%61.1%NVO
ROA

Return on assets

9.1%18.9%NVO
ROIC

Return on invested capital

13.1%29.5%NVO

Growth

Compare revenue and earnings growth rates

AZN.L: 3NVO: 3
MetricAZN.LNVOWinner
Revenue Growth (YoY)

Year-over-year revenue growth

10.9%2.3%AZN.L
Revenue Growth (3Y)

3-year revenue CAGR

9.9%18.9%NVO
Revenue Growth (5Y)

5-year revenue CAGR

14.9%18.5%NVO
EPS Growth (YoY)

Year-over-year EPS growth

48.3%1.8%AZN.L
EPS Growth (3Y)

3-year EPS CAGR

46.0%23.5%AZN.L
EPS Growth (5Y)

5-year EPS CAGR

20.4%20.7%NVO

Balance Sheet & Risk

Compare financial stability and debt levels

AZN.L: 4NVO: 1
MetricAZN.LNVOWinner
Debt/Equity

Debt to equity ratio

0.610.67AZN.L
Current Ratio

Current assets to current liabilities

0.940.80AZN.L
Quick Ratio

Quick assets to current liabilities

0.720.57AZN.L
Interest Coverage

EBIT to interest expense

8.4318.83NVO
Beta

Stock volatility vs market

0.230.27AZN.L
Summary
NVO wins 2-1

Valuation

NVO

Profitability

NVO

Growth

Tie

Balance Sheet

AZN.L

NVO is more attractively valued. NVO shows stronger profitability. AZN.L has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into AZN.L and NVO with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/AZN.L/vs/NVO" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare AZN.L vs NVO on stockvs.app
</a>